Absolutely, vaccine manufacturing will be done in a separate building. But screwups like this have potential to have sitewide impacts, particularly in the pre-approval inspection stage.
We are in a national emergency, so that will factor here. It's just worth it to highlight the risk, IMO.
Market Data 
Markets 
AI
